Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Journey Medical (DERM) Short-Term Debt repayments (2021 - 2023)

Journey Medical (DERM) has disclosed Short-Term Debt repayments for 3 consecutive years, with $3.0 million as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Short-Term Debt repayments changed N/A year-over-year to $3.0 million, compared with a TTM value of $30.9 million through Dec 2023, up 980.59%, and an annual FY2023 reading of $30.9 million, up 980.59% over the prior year.
  • Short-Term Debt repayments was $3.0 million for Q2 2023 at Journey Medical, down from $27.9 million in the prior quarter.
  • Across five years, Short-Term Debt repayments topped out at $27.9 million in Q1 2023 and bottomed at $812000.0 in Q1 2022.
  • Average Short-Term Debt repayments over 3 years is $6.9 million, with a median of $2.1 million recorded in 2022.
  • The sharpest move saw Short-Term Debt repayments surged 131.08% in 2022, then surged 3341.87% in 2023.
  • Year by year, Short-Term Debt repayments stood at $888000.0 in 2021, then surged by 131.08% to $2.1 million in 2022, then soared by 46.2% to $3.0 million in 2023.
  • Business Quant data shows Short-Term Debt repayments for DERM at $3.0 million in Q2 2023, $27.9 million in Q1 2023, and $2.1 million in Q4 2022.